Compare Stryker Corporation (SYK) vs TKO Group Holdings Inc (TKO) Price & Performance

Stryker Corporation (SYK) trades at $276.43, down 8.81% over 24 hours, reflecting bearish technical signals but strong fundamentals. The stock shows robust profitability with a 14.43% net income margin and consistent earnings beats in recent quarters. Recent developments include the launch of an FDA-cleared surgical app for Apple Vision Pro and the acquisition of ZuriMED to expand shoulder care offerings. Analyst consensus remains strongly bullish with a $372.89 price target, though ongoing securities fraud investigations pose near-term sentiment risks.

Outlook is positive long-term due to solid financial health, innovation pipeline, and institutional support, but investors face volatility from legal probes and technical bearishness. The stock's current dip may present a buying opportunity for those confident in Stryker's market position and growth trajectory, balanced against regulatory and market risks.

TKO trades at $195.32, up 5.01% today, with a bullish technical outlook and strong analyst support. The stock shows solid revenue growth, with 2026 revenue projected at $5.3B, and maintains a net income margin of 4.33%. Recent news highlights media rights strength and dividend declarations, reinforcing positive sentiment.

The outlook is positive, driven by media rights monetization and earnings growth potential, though high valuation multiples and mixed quarterly earnings pose risks. Analyst consensus is strongly bullish with a $228.17 price target, indicating ~17% upside from current levels.